Page 3 - Accessed May News Today

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs.

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2

PALO ALTO, Calif.--(BUSINESS WIRE)--May 23, 2024--

Restylane VOLYME is designed for contouring and volumization of the mid-face region to support patients in achieving a youthful, revitalized look The complementary Shape Up Holistic Individualized

Galderma SWXGALD announced today the launch of its hyaluronic acid injectable filler Restylane VOLYME in China.

Joyce F. Liu, MD, MPH, provides insights on WEE1 which has emerged as a potentially targetable pathway in high-grade serous ovarian cancer.

In honor of Asian American/Pacific Islander Heritage Month, we had a discussion on how best to support AAPI youth and their families.

Embracing movement as theory.

Learn about the Social Security COLA projection for 2025, including what it is, how it's calculated and what it means for your retirement.

Hideho Okada, MD, PhD, discusses cancer immunoprevention through the lens of vaccine approaches in patients with low-grade glioma.